Nu Skin Enterprises manufactures and markets anti-aging skincare, personal care products, and nutritional supplements primarily through a direct-selling network of independent distributors operating in nearly fifty countries. Flagship lines such as Nu Skin, Pharmanex, and ageLOC combine scientific research with consumer formulations sold via person-to-person and digital channels. Distributors earn retail margins on product sales and performance incentives based on the volume generated by their recruited sales organizations.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q1 2025 | 364.5 | — | 107.5 | 2,317.2% |
| Q2 2025 | 386.1 | — | 21.1 | 102.5% |
| Q3 2025 | 364.2 | — | 17.1 | 102.1% |
| Q4 2025 | 370.3 | — | 14.5 | -23.3% |
| Q1 2026 | 320.6 | -12% | 1.8 | -98.3% |
All markets — KeepWinning global stock screener
Other companies on NYSE: Disciplined Growth Acquisition Corporation (DGAC), Claros Mortgage Trust, Inc. (CMTG), TriplePoint Venture Growth BDC Corp. (TPVG), X Financial (XYF), Torrid Holdings Inc. (CURV), TPG Mortgage Investment Trust, Inc. (MITT)